Top Adding - Legal

What can be protected?

Determining what qualifies as a patentable invention is a highly di

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

fficult and complicated task. Patent laws state that “Anything under the sun that was inven

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ted by man qualifies as patentable”. Simple enough, but if you notice, there are hundreds o

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

pages full of exceptions and details on the idea of patentability following this phrase. S

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

cores of appeals and patent court cases have arisen due to questions regarding patentabilit

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

because it still hasn’t, and probably never will be entirely pinned down.

So, defining wh

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

at is patentable is not as clear cut as black and white. Inventions can encompass a wide va

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

iety of areas, even living subject matter so long as the subject matter is the result of hu

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

man intervention. An example of a patentable living organism is a microorganism or a plant

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

hich is produced or altered through genetic engineering. The key is that the living matter

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

must be a product of “human ingenuity” and not merely a naturally occurring object, such as

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

a shrimp with its digestive tract removed. The living matter must be altered to yield uniq

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

e properties for it to be patentable.

However, the alteration can even be the mere fact th

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

at the living matter is simply isolated or purified. For example, unaltered pieces of DNA m

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

y be patentable provided they have been sequenced. The PTO has decided that the act of isol

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ating and sequencing a strand of DNA is the result of human intervention. Currently, there

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

s huge debate surrounding the patenting of biotechnology related “inventions” like DNA. Is

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

a piece of DNA really an invention at all? Or what about a microorganism that happens to de

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

rade oil? Is that an invention? Should it be?

As you are probably starting to see, the pat

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ent office has its work cut out for them as many of these questions are not black and white

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.topadding.org.ua/article/130800/topadding-Short-Guide-to-Patent-Protection-and-Patentability.html">Short Guide to Patent Protection and Patentability</a>

BB link (for phorums):
[url=http://www.topadding.org.ua/article/130800/topadding-Short-Guide-to-Patent-Protection-and-Patentability.html]Short Guide to Patent Protection and Patentability[/url]

There are five specific caps a person can wear at work. Each cap identifies where you are most likely to have the greatest success in the marketplace. Here is a brief description of each one.

In their quest to become profitable all new traders will find new concepts as they try to understand and get educated about how the forex markets work.

Tags

Links

Top Adding - Short Guide to Patent Protection and Patentability

Related Articles: